Recent health news highlights major developments in the pharmaceutical industry, covering GSK's progress in ovarian cancer ...
The latest updates in the health sector involve significant trials and approvals. GSK's ovarian cancer drug trial met its ...
GSK’s FIRST-ENGOT-OV44 phase III clinical trial of Zejula and Jemperl in first line advanced ovarian cancer meets primary endpoint: London Saturday, December 21, 2024, 09:00 Hrs ...